A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity
Sea anemones are a remarkable source of active principles due to a decentralized venom system. New blood vessel growth or angiogenesis is a very promising target against cancer, but the few available antiangiogenic compounds have limited efficacy. In this study, a protein fraction, purified from ten...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-04-01
|
| Series: | Marine Drugs |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1660-3397/16/4/134 |
| _version_ | 1798005248021757952 |
|---|---|
| author | Erwann P. Loret José Luis Christopher Nuccio Claude Villard Pascal Mansuelle Régine Lebrun Pierre Henri Villard |
| author_facet | Erwann P. Loret José Luis Christopher Nuccio Claude Villard Pascal Mansuelle Régine Lebrun Pierre Henri Villard |
| author_sort | Erwann P. Loret |
| collection | DOAJ |
| description | Sea anemones are a remarkable source of active principles due to a decentralized venom system. New blood vessel growth or angiogenesis is a very promising target against cancer, but the few available antiangiogenic compounds have limited efficacy. In this study, a protein fraction, purified from tentacles of Anemonia viridis, was able to limit endothelial cells proliferation and angiogenesis at low concentration (14 nM). Protein sequences were determined with Edman degradation and mass spectrometry in source decay and revealed homologies with Blood Depressing Substance (BDS) sea anemones. The presence of a two-turn alpha helix observed with circular dichroism and a trypsin activity inhibition suggested that the active principle could be a Kunitz-type inhibitor, which may interact with an integrin due to an Arginine Glycin Aspartate (RGD) motif. Molecular modeling showed that this RGD motif was well exposed to solvent. This active principle could improve antiangiogenic therapy from existing antiangiogenic compounds binding on the Vascular Endothelial Growth Factor (VEGF). |
| first_indexed | 2024-04-11T12:37:13Z |
| format | Article |
| id | doaj.art-f55f88ae0748401d861a667ba78c16a2 |
| institution | Directory Open Access Journal |
| issn | 1660-3397 |
| language | English |
| last_indexed | 2024-04-11T12:37:13Z |
| publishDate | 2018-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Marine Drugs |
| spelling | doaj.art-f55f88ae0748401d861a667ba78c16a22022-12-22T04:23:36ZengMDPI AGMarine Drugs1660-33972018-04-0116413410.3390/md16040134md16040134A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic ActivityErwann P. Loret0José Luis1Christopher Nuccio2Claude Villard3Pascal Mansuelle4Régine Lebrun5Pierre Henri Villard6Aix-Marseille University (AMU), Université d’Avignon, Centre National de la Recherche Scientifique (CNRS), Institut de la Recherche et du Développement (IRD), Institut Méditerranéen de Biologie et d’Ecologie. CNRS UMR 7263 IRD 237 Faculté de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille, FranceAMU, CNRS, Institut de Neurophysio Pathologie, 13385 Marseille, FranceAMU, Institut National de la Santé Et de la Recherche Scientifique, 13385 Marseille, FranceAMU, CNRS, Institut de Neurophysio Pathologie, 13385 Marseille, FranceAMU, CNRS Formation de Recherche 3479, Institut de Microbiologie de la Méditerranée, Plateforme Protéomique, 31 Chemin Joseph Aiguier, 13402 Marseille, FranceAMU, CNRS Formation de Recherche 3479, Institut de Microbiologie de la Méditerranée, Plateforme Protéomique, 31 Chemin Joseph Aiguier, 13402 Marseille, FranceAix-Marseille University (AMU), Université d’Avignon, Centre National de la Recherche Scientifique (CNRS), Institut de la Recherche et du Développement (IRD), Institut Méditerranéen de Biologie et d’Ecologie. CNRS UMR 7263 IRD 237 Faculté de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille, FranceSea anemones are a remarkable source of active principles due to a decentralized venom system. New blood vessel growth or angiogenesis is a very promising target against cancer, but the few available antiangiogenic compounds have limited efficacy. In this study, a protein fraction, purified from tentacles of Anemonia viridis, was able to limit endothelial cells proliferation and angiogenesis at low concentration (14 nM). Protein sequences were determined with Edman degradation and mass spectrometry in source decay and revealed homologies with Blood Depressing Substance (BDS) sea anemones. The presence of a two-turn alpha helix observed with circular dichroism and a trypsin activity inhibition suggested that the active principle could be a Kunitz-type inhibitor, which may interact with an integrin due to an Arginine Glycin Aspartate (RGD) motif. Molecular modeling showed that this RGD motif was well exposed to solvent. This active principle could improve antiangiogenic therapy from existing antiangiogenic compounds binding on the Vascular Endothelial Growth Factor (VEGF).http://www.mdpi.com/1660-3397/16/4/134sea anemonedrug discoverycancerantiangiogenicendothelial cellsRGD motifkunitz type inhibitor |
| spellingShingle | Erwann P. Loret José Luis Christopher Nuccio Claude Villard Pascal Mansuelle Régine Lebrun Pierre Henri Villard A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity Marine Drugs sea anemone drug discovery cancer antiangiogenic endothelial cells RGD motif kunitz type inhibitor |
| title | A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity |
| title_full | A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity |
| title_fullStr | A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity |
| title_full_unstemmed | A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity |
| title_short | A Low Molecular Weight Protein from the Sea Anemone Anemonia viridis with an Anti-Angiogenic Activity |
| title_sort | low molecular weight protein from the sea anemone anemonia viridis with an anti angiogenic activity |
| topic | sea anemone drug discovery cancer antiangiogenic endothelial cells RGD motif kunitz type inhibitor |
| url | http://www.mdpi.com/1660-3397/16/4/134 |
| work_keys_str_mv | AT erwannploret alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT joseluis alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT christophernuccio alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT claudevillard alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT pascalmansuelle alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT reginelebrun alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT pierrehenrivillard alowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT erwannploret lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT joseluis lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT christophernuccio lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT claudevillard lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT pascalmansuelle lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT reginelebrun lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity AT pierrehenrivillard lowmolecularweightproteinfromtheseaanemoneanemoniaviridiswithanantiangiogenicactivity |